REGENERON PHARMACEUTICALS, INC. (REGN)

SEC filing

REGENERON PHARMACEUTICALS, INC.

REGN · CIK 872589

4 · Aug 21, 2026 · EVP General Counsel and Secret LAROSA JOSEPH J exercised options for 24.56K shares; reported 9,019 shares

EVP General Counsel and Secret LAROSA JOSEPH J exercised options for 24.56K shares; reported 9,019 shares

PRIMARY DOCUMENT

xslF345X06/edgardoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).